BALCAO · SERVICES-MISC HEALTH & ALLIED SERVICES, NEC · SMALL CAP
Pacific Health Care Organization, Inc. PFHO
16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$6.7M
▲ 10.7% vs FY2024
EPS · FY25
$0.11
Dividend / sh · FY25
—
Payout · FY25
3%
ROE · FY25
11.2%
Net margin · FY25
20.7%
Dividend coverage
0.6×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 6.7M
Revenue, FY2025 · full 16-year series below
Revenue
Net income
21 cents of every revenue dollar became profit this year.
Per share
USD 0.11
Diluted EPS, FY2025
EPS
Dividend
Earnings covered only a fraction of the dividend — the rest came from cash or borrowing.
Profitability
11.2%
Return on equity, FY2025
ROE
Operating margin14.9%
Net margin20.7%
Return on assets10.7%
Each USD of equity produced 11 cents of profit this year.
Returned to shareholders
USD 37,000.00
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 37,000.00
Net buybacks—
Share of profit2.7%
Consecutive raises—
USD 37,000.00 in dividends — 3% of the year's profit went back to shareholders.
Growth
+2.1% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+5.3%
+2.1%
−2.0%
+10.0%
Net income
+41.2%
+20.4%
−1.9%
EPS, diluted
+40.1%
+22.4%
Returned to shareholders
−28.8%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2025
Change, 5 years+0.0%
Change, 10 years—
The share count grew 0% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 13.5M
total assets, end of FY2025
Total assetsUSD 13.5M
EquityUSD 13.1M
CashUSD 2.2M
Current ratio34.45×
Equity funds 97% of total assets.
History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
EBITDA $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
Net income $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
EPS, diluted $
0.11
0.07
0.06
0.04
0.08
0.04
0.09
0.11
0.30
0.71
2.10
2.45
1.54
0.89
0.25
−0.08
Dividend / sh $
·
·
0.10
·
·
·
·
·
·
·
·
·
·
0.00
0.00
·
Payout %
3
0
167
0
·
·
0
1
0
0
56
0
0
0
·
·
ROE %
11.2
7.9
6.9
4.5
9.6
5.8
13.8
18.4
15.5
10.4
34.4
53.3
58.0
61.8
28.5
−10.0
Shares out B
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
47 of 47
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed